- Investing Ideas
- Danish Pharmaceuticals & Biotech Potentially Undervalued Companies
Danish Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
5
Companies with a Value score of at least 3, ordered by Value score
5 companies
Bavarian Nordic
Market Cap: DKK 16.1b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 212.60
7D
10.0%
1Y
-10.3%
H. Lundbeck
Market Cap: DKK 41.3b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 41.80
7D
-1.6%
1Y
3.1%
Novo Nordisk
Market Cap: DKK 1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 304.95
7D
1.8%
1Y
-14.5%
H. Lundbeck
Market Cap: DKK 41.3b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN A
DKK 41.35
7D
-1.4%
1Y
22.9%
Strategic Partners
Market Cap: DKK 29.0m
Does not have significant operations.
STRAP
DKK 695.00
7D
0.7%
1Y
-33.2%